Is It Really Duct Carcinoma In Situ?

This publication has 21 references indexed in Scilit:

• Sentinel Node Biopsy for Patients With DCIS: A Dangerous and Unwarranted Direction
  Annals of Surgical Oncology, 2001
• Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?
  Annals of Surgical Oncology, 2000
• Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
  New England Journal of Medicine, 2000
• Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853
  The Lancet, 2000
• Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
  The Lancet, 1999
• Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
  The Lancet, 1999
• Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy.
  American Journal of Roentgenology, 1999
• Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
  JNCI Journal of the National Cancer Institute, 1996
• Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer
  New England Journal of Medicine, 1993
• Borderline Epithelial Lesions of the Breast
  The American Journal of Surgical Pathology, 1991